STACEY KESTERSON: Open Payments
NPI 1073594263 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 18 payments from 11 companies in 2025. Trend: 2023 $883 · 2024 $521 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 6 | $55 |
| Novo Nordisk Inc | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| MILLICENT US INC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
Products named: Ozempic, GVOKE HYPOPEN, VOQUEZNA, Veozah, CAPLYTA, INTRAROSA, HETLIOZ, Auvelity.
Industry payments across TN — which companies pay providers there.
